Autobio Diagnostics
Launch date
Employees
Market cap
AUD4.7b
Enterprise valuation
AUD4.7b (Public information from Sep 2024)
Share price
CNY38.89 603658.SS
China (HQ)
Financials
Estimates*
CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 3.0b | 3.8b | 4.4b | 4.4b | 4.9b | 5.8b | 6.7b |
% growth | 11 % | 26 % | 18 % | - | 10 % | 18 % | 17 % |
EBITDA | 1.2b | 1.5b | 1.8b | 1.9b | 1.9b | 2.2b | 2.6b |
% EBITDA margin | 41 % | 40 % | 41 % | 43 % | 38 % | 38 % | 38 % |
Profit | 748m | 974m | 1.2b | 1.2b | 1.4b | 1.7b | 2.1b |
% profit margin | 25 % | 26 % | 26 % | 27 % | 29 % | 30 % | 31 % |
EV / revenue | 22.0x | 8.4x | 7.9x | 7.3x | 4.6x | 3.8x | 3.1x |
EV / EBITDA | 54.3x | 21.3x | 19.5x | 17.1x | 12.0x | 9.9x | 8.1x |
R&D budget | 343m | 481m | 568m | 656m | - | - | - |
R&D % of revenue | 12 % | 13 % | 13 % | 15 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
Total Funding | - |
Recent News about Autobio Diagnostics
EditInvestments by Autobio Diagnostics
EditACQUISITION by Hologic Apr 2021